Roivant Discovery, the drug discovery engine for Roivant Sciences, is a leader in the development and deployment of advanced computational methods for drug discovery. To overcome challenging bottlenecks in drug discovery, we bring together scientific method developers, software engineers, and high-performance computing experts who formulate purpose-built algorithms with experienced drug hunters with deep expertise in medicinal chemistry, biophysics, biochemistry and disease biology.
Roivant Discovery has a differentiated pipeline of targets with high biological and disease validation that have historically been challenging to design therapeutics. Roivant Discovery has created the preeminent computational platform for drug discovery, with advanced physics-based and AI/ML capabilities ranging from target discovery through lead optimization. Working together, our drug discovery team and computational platform systematically connects targets with diseases at the atomic scale. This synergistic approach delivers detailed molecular design insights and therapeutic hypotheses, which we interrogate with bespoke methods to solve specific problems, thus enabling us to evaluate a vast number of drug candidates against the desired biological outcome and test the most promising molecules in the Roivant Discovery laboratories.